Benzathine penicillin G
Benzathine penicillin G is a pharmaceutical drug with 7 clinical trials. Currently 2 active trials ongoing. Historical success rate of 50.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
50.0%
1 of 2 finished
50.0%
1 ended early
2
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy
Treatment Responses of Early Syphilis to Ceftriaxone Plus Doxycycline
Comparisons of Treatment Responses of Early Syphilis to Benzathine Penicillin G With or Without Doxycycline
Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis
Cefixime for Alternative Syphilis Treatment
Clinical Trials (7)
Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy
Treatment Responses of Early Syphilis to Ceftriaxone Plus Doxycycline
Comparisons of Treatment Responses of Early Syphilis to Benzathine Penicillin G With or Without Doxycycline
Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis
Cefixime for Alternative Syphilis Treatment
The Association Between Molecular Typing of Treponema Pallidum and Treatment Efficacy and Clinical Findings
One Dose Versus Three Weekly Doses of Benzathine Penicillin G for Patients With Early Syphilis
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7